Published in Mol Syndromol on June 03, 2016
The Relationship between Mitochondrial Respiratory Chain Activities in Muscle and Metabolites in Plasma and Urine: A Retrospective Study. J Clin Med (2017) 0.78
The Effect of Mitochondrial Supplements on Mitochondrial Activity in Children with Autism Spectrum Disorder. J Clin Med (2017) 0.76
Identification of miRNA, lncRNA and mRNA-associated ceRNA networks and potential biomarker for MELAS with mitochondrial DNA A3243G mutation. Sci Rep (2017) 0.75
Bioenergetic variation is related to autism symptomatology. Metab Brain Dis (2017) 0.75
Common data elements for clinical research in mitochondrial disease: a National Institute for Neurological Disorders and Stroke project. J Inherit Metab Dis (2017) 0.75
Mitochondrial Dynamics in Mitochondrial Diseases. Diseases (2016) 0.75
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature (1993) 21.65
Principles of cancer therapy: oncogene and non-oncogene addiction. Cell (2009) 10.96
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet (2004) 7.45
Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry (2011) 6.98
Loss of PINK1 function promotes mitophagy through effects on oxidative stress and mitochondrial fission. J Biol Chem (2009) 4.90
Prevalence of mitochondrial DNA disease in adults. Ann Neurol (2008) 4.72
The familial risk of autism. JAMA (2014) 4.28
Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol (2007) 3.90
The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol Psychiatry (2006) 3.63
Mitochondrial dynamics--mitochondrial fission and fusion in human diseases. N Engl J Med (2013) 3.33
Diagnostic criteria for respiratory chain disorders in adults and children. Neurology (2002) 3.12
Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain (2003) 2.59
Narrative review: statin-related myopathy. Ann Intern Med (2009) 2.36
Mutation of succinate dehydrogenase subunit C results in increased O2.-, oxidative stress, and genomic instability. Cancer Res (2006) 2.27
Whole-genome sequencing of quartet families with autism spectrum disorder. Nat Med (2015) 2.20
Effect of coenzyme q10 on myopathic symptoms in patients treated with statins. Am J Cardiol (2007) 2.20
Energetics, epigenetics, mitochondrial genetics. Mitochondrion (2009) 2.08
Mitochondrial dysfunction in autism. JAMA (2010) 2.04
Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics (2004) 1.95
Treatment for mitochondrial disorders. Cochrane Database Syst Rev (2012) 1.94
Understanding mitochondrial complex I assembly in health and disease. Biochim Biophys Acta (2011) 1.86
A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures. Mol Psychiatry (2011) 1.85
Endurance exercise rescues progeroid aging and induces systemic mitochondrial rejuvenation in mtDNA mutator mice. Proc Natl Acad Sci U S A (2011) 1.81
Use of L-asparaginase in childhood ALL. Crit Rev Oncol Hematol (1998) 1.69
Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med (2013) 1.69
Medication-induced mitochondrial damage and disease. Mol Nutr Food Res (2008) 1.68
Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol (1999) 1.66
Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial. Lancet Neurol (2007) 1.64
Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N Engl J Med (2008) 1.63
L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology (2005) 1.63
Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia. J Neurol Sci (2005) 1.62
Severe depletion of mitochondrial DNA in spinal muscular atrophy. Acta Neuropathol (2002) 1.60
Mitochondrial disease criteria: diagnostic applications in children. Neurology (2006) 1.58
Mitochondrial dysfunction: a neglected component of skin diseases. Exp Dermatol (2014) 1.58
Mitochondrial dysfunction in cancer. Front Oncol (2013) 1.57
Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology. Kidney Int (2013) 1.46
Mitochondrial dynamics in diabetes. Antioxid Redox Signal (2010) 1.46
Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve (2007) 1.45
Mitochondrial disorders: a proposal for consensus diagnostic criteria in infants and children. Neurology (2002) 1.43
Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol (2010) 1.32
Mitochondrial cytopathies. J Neurol (2003) 1.28
Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med (2014) 1.27
The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies. Adv Drug Deliv Rev (2008) 1.26
MELAS and L-arginine therapy: pathophysiology of stroke-like episodes. Ann N Y Acad Sci (2010) 1.22
Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. Med Sci Sports Exerc (2005) 1.20
Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort. PLoS One (2014) 1.20
Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics. Mitochondrion (2013) 1.17
Mitochondrial dynamics in cardiovascular health and disease. Antioxid Redox Signal (2012) 1.17
Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility. Clin Endocrinol (Oxf) (2003) 1.14
Coenzyme Q10 and statins: biochemical and clinical implications. Mitochondrion (2007) 1.14
Reactive oxygen species at the crossroads of inflammasome and inflammation. Front Physiol (2014) 1.12
DNA repair in organelles: Pathways, organization, regulation, relevance in disease and aging. Biochim Biophys Acta (2010) 1.10
Transmission of mitochondrial DNA diseases and ways to prevent them. PLoS Genet (2010) 1.08
Nuclear-encoded factors involved in post-transcriptional processing and modification of mitochondrial tRNAs in human disease. Front Genet (2015) 1.05
Application of whole exome sequencing to identify disease-causing variants in inherited human diseases. Genomics Inform (2012) 1.05
Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-γ inhibition. Trends Pharmacol Sci (2011) 1.04
Mitochondrial dysfunction and Down's syndrome. Bioessays (2002) 1.04
Whole exome sequencing of suspected mitochondrial patients in clinical practice. J Inherit Metab Dis (2015) 1.04
Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatr Res (2009) 1.04
Deficit of complex I activity in human skin fibroblasts with chromosome 21 trisomy and overproduction of reactive oxygen species by mitochondria: involvement of the cAMP/PKA signalling pathway. Biochem J (2011) 1.03
Multiple mtDNA deletions features in autosomal dominant and recessive diseases suggest distinct pathogeneses. Neurology (1998) 1.02
A randomized trial of coenzyme Q10 in mitochondrial disorders. Muscle Nerve (2010) 1.01
Mitochondria: commanders of innate immunity and disease? Curr Opin Immunol (2011) 1.01
Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Int J Clin Exp Med (2012) 1.01
Three phases of DiGeorge/22q11 deletion syndrome pathogenesis during brain development: patterning, proliferation, and mitochondrial functions of 22q11 genes. Int J Dev Neurosci (2010) 1.00
Mitochondrial dysfunction in Pten haplo-insufficient mice with social deficits and repetitive behavior: interplay between Pten and p53. PLoS One (2012) 1.00
Investigating drug-induced mitochondrial toxicity: a biosensor to increase drug safety? Curr Drug Saf (2009) 0.99
Contribution of glutathione status to oxidant-induced mitochondrial DNA damage in colonic epithelial cells. Free Radic Biol Med (2009) 0.99
Oxidative Stress and Down Syndrome: A Route toward Alzheimer-Like Dementia. Curr Gerontol Geriatr Res (2011) 0.98
Keeping mtDNA in shape between generations. PLoS Genet (2014) 0.98
Low mutational burden of individual acquired mitochondrial DNA mutations in brain. Genomics (2001) 0.97
Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses. BMC Med (2015) 0.97
Characterization of a 8q21.11 microdeletion syndrome associated with intellectual disability and a recognizable phenotype. Am J Hum Genet (2011) 0.96
Effect of influenza vaccination on oxidative stress products in breath. J Breath Res (2010) 0.96
Mitochondrial dysfunction in aging: Much progress but many unresolved questions. Biochim Biophys Acta (2015) 0.94
Review of clinical trials for mitochondrial disorders: 1997-2012. Neurotherapeutics (2013) 0.94
The role of mitochondrial dysfunction in age-related diseases. Biochim Biophys Acta (2015) 0.94
The PRPP synthetase spectrum: what does it demonstrate about nucleotide syndromes? Nucleosides Nucleotides Nucleic Acids (2011) 0.94
Oxidative stress and mitochondrial dysfunction in Down syndrome. Adv Exp Med Biol (2012) 0.93
Mitochondria are gate-keepers of T cell function by producing the ATP that drives purinergic signaling. J Biol Chem (2014) 0.93
Oxidative burden and mitochondrial dysfunction in a mouse model of Rett syndrome. Neurobiol Dis (2012) 0.93
Mitochondrial disease in childhood: mtDNA encoded. Neurotherapeutics (2013) 0.93
Mitochondrial dysfunction in neuromuscular disorders. Semin Pediatr Neurol (2013) 0.92
Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes. Toxicol Appl Pharmacol (2009) 0.91
Mitochondrial pathophysiology in Friedreich's ataxia. J Neurochem (2013) 0.91
Treatment of mitochondrial disorders. Curr Treat Options Neurol (2014) 0.90
Immune mediated conditions in autism spectrum disorders. Brain Behav Immun (2015) 0.88
How advances in immunology provide insight into improving vaccine efficacy. Vaccine (2014) 0.88
Mitochondrial DNA mutations in RRF of healthy subjects of different age. Neurobiol Aging (2005) 0.87
Mitochondrial dysfunction and defective autophagy in the pathogenesis of collagen VI muscular dystrophies. Cold Spring Harb Perspect Biol (2013) 0.87
Mitochondrial DNA mutations in neurodegeneration. Biochim Biophys Acta (2015) 0.86
Mitochondria as a pharmacological target: magnum overview. IUBMB Life (2013) 0.86
Preventing the transmission of mitochondrial DNA disorders using prenatal or preimplantation genetic diagnosis. Ann N Y Acad Sci (2015) 0.86
Long-term aerobic exercise is associated with greater muscle strength throughout the life span. J Gerontol A Biol Sci Med Sci (2012) 0.86
Quantitative assessment of heteroplasmy of mitochondrial genome: perspectives in diagnostics and methodological pitfalls. Biomed Res Int (2014) 0.86
A peep into mitochondrial disorder: multifaceted from mitochondrial DNA mutations to nuclear gene modulation. Protein Cell (2015) 0.84
Apoptosis and necrosis mediate skeletal muscle fiber loss in age-induced mitochondrial enzymatic abnormalities. Aging Cell (2015) 0.83
Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophies. Biochim Biophys Acta (1995) 0.83
The otolaryngological manifestations of mitochondrial disease and the risk of neurodegeneration with infection. Arch Otolaryngol Head Neck Surg (2002) 0.83
Antioxidants and other pharmacological treatments for Friedreich ataxia. Cochrane Database Syst Rev (2012) 0.82